Electrophysiology Device with Electrodes Having Increased Surface Area
20230240744 · 2023-08-03
Inventors
- Derek Sutermeister (Ham Lake, MN, US)
- Edward E. Parsonage (St. Paul, MN, US)
- Gregory K. Olson (Elk River, MN, US)
Cpc classification
C25D7/00
CHEMISTRY; METALLURGY
A61B2018/1467
HUMAN NECESSITIES
C25D5/34
CHEMISTRY; METALLURGY
A61B18/1492
HUMAN NECESSITIES
C23C14/022
CHEMISTRY; METALLURGY
A61N1/05
HUMAN NECESSITIES
International classification
Abstract
A medical device includes a body and at least one electrode disposed thereon. The electrode includes a metallic substrate, such as a platinum group metal, an alloy of platinum group metals, or gold. The surface of the substrate is modified in a manner that increases its effective surface area without inducing bulk heating. For example, the surface of the substrate can be laser textured and/or coated, such as with titanium nitride or iridium oxide.
Claims
1-25. (canceled)
26. A method of manufacturing a medical device, comprising: forming a medical device body; forming at least one electrode according to a process comprising: forming a metallic substrate; applying a coating to a surface of the metallic substrate; and treating the surface of the metallic substrate in a manner that increases a surface area of the metallic substrate and that reduces resistance of the metallic substrate when operating at a frequency within a cardiac medical range; and securing the at least one electrode to the medical device body.
27. The method according to claim 26, wherein the treating step comprises creating a textured surface on the metallic substrate.
28. The method according to claim 27, wherein the textured surface includes a plurality of peaks and valleys extending uniformly along at least one dimension.
29. The method according to claim 26, wherein the treating step comprises laser etching the surface of the metallic substrate.
30. The method according to claim 26, wherein the coating comprises a metallic coating.
31. The method according to claim 30, wherein the metallic coating comprises at least one of titanium nitride, iridium oxide, platinum, and platinum-iridium.
32. The method according to claim 26, wherein the coating comprises an electrically-conductive polymer coating.
33. The method according to claim 26, wherein applying the coating to the surface of the metallic substrate comprises applying the coating to the surface of the metallic substrate via physical vapor deposition.
34. The method according to claim 26, wherein applying the coating to the surface of the metallic substrate comprises applying the coating to the surface of the metallic substrate via chemical vapor deposition.
35. The method according to claim 26, wherein applying the coating to the surface of the metallic substrate comprises applying the coating to the surface of the metallic substrate via electrochemical deposition.
36. A medical device, formed according to a process comprising: forming a medical device body; forming at least one electrode according to a process comprising: forming a metallic substrate; applying a coating to a surface of the metallic substrate; and treating the surface of the metallic substrate in a manner that increases a surface area of the metallic substrate and that reduces resistance of the metallic substrate when operating at a frequency within a cardiac medical range; and securing the at least one electrode to the medical device body.
37. The medical device according to claim 36, wherein the treating step comprises creating a textured surface on the metallic substrate.
38. The medical device according to claim 37, wherein the textured surface includes a plurality of peaks and valleys extending uniformly along at least one dimension.
39. The medical device according to claim 36, wherein the treating step comprises laser etching the surface of the metallic substrate.
40. The medical device according to claim 36, wherein the coating comprises a metallic coating.
41. The medical device according to claim 40, wherein the metallic coating comprises at least one of titanium nitride, iridium oxide, platinum, and platinum-iridium.
42. The medical device according to claim 36, wherein the coating comprises an electrically-conductive polymer coating.
43. The medical device according to claim 36, wherein applying the coating to the surface of the metallic substrate comprises applying the coating to the surface of the metallic substrate via physical vapor deposition.
44. The medical device according to claim 36, wherein applying the coating to the surface of the metallic substrate comprises applying the coating to the surface of the metallic substrate via chemical vapor deposition.
45. The medical device according to claim 36, wherein applying the coating to the surface of the metallic substrate comprises applying the coating to the surface of the metallic substrate via electrochemical deposition.
46. A medical device comprising: a medical device body; at least one electrode secured to the medical device body, the at least one electrode comprising: a metallic substrate having a surface, wherein the surface includes a surface treatment that increases a surface area of the metallic substrate and that reduces resistance of the metallic substrate when operating at a frequency within a cardiac medical range; and a coating applied to the surface of the metallic substrate.
47. The medical device according to claim 46, wherein the surface treatment comprises a textured surface.
48. The medical device according to claim 47, wherein the textured surface includes a plurality of peaks and valleys extending uniformly along at least one dimension.
49. The medical device according to claim 46, wherein the surface treatment comprises a laser-etched pattern.
50. The medical device according to claim 46, wherein the coating comprises a metallic coating.
51. The medical device according to claim 50, wherein the metallic coating comprises at least one of titanium nitride, iridium oxide, platinum, and platinum-iridium.
52. The medical device according to claim 46, wherein the coating comprises an electrically-conductive polymer coating.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0013]
[0014]
[0015]
DETAILED DESCRIPTION
[0016] For purposes of illustration, the present teachings will be described in connection with a multi-electrode mapping and ablation catheter 10, such as illustrated in
[0017] Various additional aspects of the construction of catheter 10 will be familiar to those of ordinary skill in the art. For example, the person of ordinary skill in the art will recognize that catheter 10 can be made steerable, for example by incorporating an actuator into handle 18 that is coupled to one or more steering wires that extend through elongate catheter body 12 and that terminate in one or more pull rings within distal region 14. Likewise, the ordinarily skilled artisan will appreciate that catheter 10 can be an irrigated catheter, such that it can also be coupled to a suitable supply of irrigation fluid and/or an irrigation pump. As a further example, those of ordinary skill in the art will appreciate that catheter 10 can be equipped with force feedback capabilities.
[0018] Insofar as such features are not necessary to an understanding of the instant disclosure, they are neither illustrated in the drawings nor explained in detail herein. By way of example only, however, catheter 10 can incorporate various aspects and features of the following catheters, all from Abbott Laboratories: the EnSite™ Array™ catheter; the FlexAbility™ ablation catheter; the Safire™ BLU™ ablation catheter; the Therapy™ Cool Path™ irrigated ablation catheter; the Livewire™ TC ablation catheter; and the TactiCath™ Quartz irrigated ablation catheter.
[0019]
[0020] Electrodes 28 may include any metal capable of detecting and conducting the local electrical signal. Suitable materials for electrodes 28 include, without limitation, platinum group metals (e.g., platinum, palladium, rhodium, osmium, ruthenium, iridium), alloys of platinum group metals (e.g., platinum-iridium alloys), and gold. In other embodiments of the disclosure, electrodes 28 include multiple layers of conductive materials, such as gold-coated copper.
[0021] Electrodes 28 can also be of various physical configurations. These include, by way of example only, ring electrodes, segmented ring electrodes, partial ring electrodes, flexible circuit electrodes, balloon electrodes, and spot electrodes. Various configurations of electrodes 28 (as well as electrode 26) are disclosed in International Publication No. WO 2016/182876, which is hereby incorporated by reference as though fully set forth herein.
[0022] The instant disclosure provides electrodes having increased microscopic surface areas (that is, electrodes with surface areas exceeding those of planar electrodes having the same or similar dimensions). According to aspects of the disclosure, the increased microscopic surface area is achieved by treating a surface 30 of the electrode substrate 32 as shown in
[0023] Electrodes having increased microscopic surface areas can be employed to good advantage in various electrophysiology devices including, without limitation, electrophysiology mapping catheters (e.g., basket catheters, HD grid catheters) and ablation catheters. The basic structure of such devices will be familiar to those of ordinary skill in the art, and are also illustrated in, inter alia, international application no. PCT/US2018/046953, United States patent application publication no. 2017/0112405, and U.S. Pat. No. 8,560,086, all of which are hereby incorporated by reference as though fully set forth herein. It should be understood, however, that the foregoing are merely representative of certain types of electrophysiology devices that can include electrodes according to the instant teachings; insofar as electrodes according to the instant disclosure can be employed to good advantage in other contexts, the foregoing list of electrophysiology devices should not be regarded as exclusive, exhaustive, or otherwise limiting.
[0024] In embodiments of the disclosure, surface 30 of electrode substrate 32 is treated by applying laser energy thereto, for example by using a femtosecond laser, to create a textured surface 30 on electrode substrate 32.
[0025] In general, the real component of the overall measured impedance (that is, the resistance) will have an interfacial component that is affected by the local ionic concentration, which results in a frequency dependency of the measured resistance. In aspects of the instant disclosure, therefore, it can be desirable for textured surface 30 to have a length scale comparable to the ionic double layer thickness (e.g., nanoscaled surfaces).
[0026] In other embodiments of the disclosure, surface 30 of electrode substrate 32 is treated by applying a coating thereto, such as a titanium nitride, iridium oxide, platinum, and platinum-iridium coatings. In other embodiments, the coating is a durable electro-conductive polymer coating, such as Amplicoat™ (Heraeus Medical Components LLC, Yardley, Pa.). The coating may be applied to substrate 32 by physical vapor deposition, chemical vapor deposition, electrochemical deposition, or the like.
[0027] In still further embodiments of the disclosure, surface 30 of electrode substrate 32 is treated both by applying laser energy thereto and by applying a coating thereto. These treatments can be carried out in either order.
[0028] In general, the amount of impedance reduction relative to a planar electrode of the same or similar dimensions that results from the foregoing treatments can depend upon factors such as electrode dimensions, signal magnitude, signal frequency, and media ionic strength. As one example, at operating frequencies within the cardiac medical range (e.g., less than about 20 kHz), and measured relative to a planar electrode having a surface area of about 1 mm.sup.2, treatments according to the instant teachings can yield impedance improvements (that is, reductions) of at least about 20%. It should also be understood that the percentage impedance improvement increases as the comparable planar electrode surface area decreases. Thus, in certain embodiments, the treatments disclosed herein can yield impedance improvements (that is, reductions) of at least about 30%, and, in some instances, of at least about 40%.
[0029] Although several embodiments have been described above with a certain degree of particularity, those skilled in the art could make numerous alterations to the disclosed embodiments without departing from the spirit or scope of this disclosure.
[0030] For example, the electrodes described herein can not only be formed prior to being attached to the body of a medical device (e.g., an electrophysiology catheter), but can also be formed following attachment to the body of the medical device.
[0031] All directional references (e.g., upper, lower, upward, downward, left, right, leftward, rightward, top, bottom, above, below, vertical, horizontal, clockwise, and counterclockwise) are only used for identification purposes to aid the reader's understanding of the present invention, and do not create limitations, particularly as to the position, orientation, or use of the invention. Joinder references (e.g., attached, coupled, connected, and the like) are to be construed broadly and may include intermediate members between a connection of elements and relative movement between elements. As such, joinder references do not necessarily infer that two elements are directly connected and in fixed relation to each other.
[0032] It is intended that all matter contained in the above description or shown in the accompanying drawings shall be interpreted as illustrative only and not limiting. Changes in detail or structure may be made without departing from the spirit of the invention as defined in the appended claims.